EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in extra-intestinal pathogenic Escherichia coli

Naoise McGarry, Domhnall Roe, Stephen G J Smith

Microbiology · 2024

DOI: 10.1099/mic.0.001493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology, 2024. Verfasst von Naoise McGarry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, School of Medicine, Trinity College, Dublin, Republic of Ireland. Hauptthemen laut MEDLINE: Lipopolysaccharides, Bacterial Capsules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Children's Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli (E. coli ) is a major cause of urinary tract infections, bacteraemia, and sepsis. CFT073 is a prototypic, urosepsis isolate of sequence type (ST) 73. This laboratory, among others, has shown that strain CFT073 is resistant to serum, with capsule and other extracellular polysaccharides imparting resistance. The interplay of such polysaccharides remains under-explored. This study has shown that CFT073 mutants deficient in lipopolysaccharide (LPS) O-antigen and capsule display exquisite serum sensitivity. Additionally, O-antigen and LPS outer core mutants displayed significantly decreased surface K2 capsule, coupled with increased unbound K2 capsule being detected in the supernatant. The R1 core and O6 antigen are involved in the tethering of K2 capsule to the CFT073 cell surface, highlighting the importance of the R1 core in serum resistance. The dependence of capsule on LPS was shown to be post-transcriptional and related to changes in cell surface hydrophobicity. Furthermore, immunofluorescence microscopy suggested that the surface pattern of capsule is altered in such LPS core mutants, which display a punctate capsule pattern. Finally, targeting LPS biosynthesis using sub-inhibitory concentrations of a WaaG inhibitor resulted in increased serum sensitivity and decreased capsule in CFT073. Interestingly, the dependency of capsule on LPS has been observed previously in other Enterobacteria , indicating that the synergy between these polysaccharides is not just strain, serotype or species-specific but may be conserved across several pathogenic Gram-negative species. Therefore, using WaaG inhibitor derivatives to target LPS is a promising therapeutic strategy to reduce morbidity and mortality by reducing or eliminating surface capsule.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesBacterial CapsulesHumansExtraintestinal Pathogenic Escherichia coliO AntigensEscherichia coli InfectionsEscherichia coliEscherichia coli ProteinsMutation

Stichwörter der Autor:innen

Escherichia coliExPECLPSantibiotic resistancecapsulepolysaccharidesserum resistance

Substanzen

LipopolysaccharidesO AntigensEscherichia coli Proteins

Autor:innen und Institutionen

  • Department of Clinical Microbiology, School of Medicine, Trinity College, Dublin, Republic of Ireland.

Förderung

  • National Children's Research Centre

Zitieren

APA

McGarry, N., Roe, D., & Smith, S. G. J. (2024). Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in extra-intestinal pathogenic Escherichia coli. Microbiology. https://doi.org/10.1099/mic.0.001493

Vancouver

McGarry N, Roe D, Smith SGJ. Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in extra-intestinal pathogenic Escherichia coli. Microbiology. 2024. doi:10.1099/mic.0.001493

BibTeX
@article{McGarry2024,
  author = {McGarry, Naoise and Roe, Domhnall and Smith, Stephen G J},
  title = {Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in extra-intestinal pathogenic Escherichia coli},
  journal = {Microbiology},
  year = {2024},
  doi = {10.1099/mic.0.001493}
}
Kostenlos starten →